The Prolyl Endopeptidase PREP Is Involved in Filaggrinolysis and Cornification.

epidermis keratinocyte post-translational modification protease terminal differentiation

Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
13 Jun 2024
Historique:
received: 22 01 2024
revised: 18 04 2024
accepted: 26 04 2024
medline: 16 6 2024
pubmed: 16 6 2024
entrez: 15 6 2024
Statut: aheadofprint

Résumé

Filaggrin (FLG) is a well-known biomarker of atopic dermatitis and skin dryness. Its full proteolysis (or filaggrinolysis) produces the major constituents of the natural moisturizing factor. Some proteases/peptidases remain to be identified in this multistep process. Mining 16 omics analyses, we identified prolyl endopeptidase (PREP) as a candidate peptidase. Indirect immunofluorescence and confocal analysis demonstrated its localization in the granular and deep cornified layers, where it co-localized with FLG. Tandem mass spectroscopy and fluorescent quenching activity assays showed that PREP cleaved several synthetic peptides derived from the FLG sequence, at the carboxyl side of an internal proline. Deimination of these peptides increased PREP enzymatic efficiency. Specific inhibition of PREP in reconstructed human epidermis (RHEs) using benzyloxycarbonyl-Pro-Prolinal (ZPP) induced the accumulation of FLG monomers. Down-regulation of PREP expression in RHEs using RNA interference confirmed the impact of PREP on FLG metabolism, and highlighted a more general role of PREP in keratinocyte differentiation. Indeed, quantitative global proteomic, Western blotting and RT-qPCR analyses showed a strong reduction in the expression of bleomycin hydrolase, known to be involved in filaggrinolysis, and of several other actors of cornification like loricrin. Consequently, at the functional level, the trans-epidermal electric resistance was drastically reduced.

Identifiants

pubmed: 38879153
pii: S0022-202X(24)00435-4
doi: 10.1016/j.jid.2024.04.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Julie Briot (J)

Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse, CNRS UMR5051 , INSERM UMR1291, Paul Sabatier University, Toulouse, France.

Carole Pons (C)

Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse, CNRS UMR5051 , INSERM UMR1291, Paul Sabatier University, Toulouse, France.

Aude Foucher (A)

L'Oréal Research & Innovation, Aulnay-sous-Bois, France.

Dominique Goudounèche (D)

CMEAB, Toulouse III University, Toulouse, France.

Nicolas Gaudenzio (N)

Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse, CNRS UMR5051 , INSERM UMR1291, Paul Sabatier University, Toulouse, France; Genoskin SAS, Toulouse, France.

Mark Donovan (M)

L'Oréal Research & Innovation, Aulnay-sous-Bois, France.

Dominique Bernard (D)

L'Oréal Research & Innovation, Aulnay-sous-Bois, France.

Marie-Claire Méchin (MC)

Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse, CNRS UMR5051 , INSERM UMR1291, Paul Sabatier University, Toulouse, France.

Michel Simon (M)

Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse, CNRS UMR5051 , INSERM UMR1291, Paul Sabatier University, Toulouse, France. Electronic address: michel.simon@inserm.fr.

Classifications MeSH